Literature DB >> 19691661

Incidence of and risk factors for ischemic-type biliary lesions following orthotopic liver transplantation.

Christoph Heidenhain1, Johann Pratschke, Gero Puhl, Ulf Neumann, Andreas Pascher, Winfried Veltzke-Schlieker, Peter Neuhaus.   

Abstract

Ischemic-type biliary lesions (ITBL) account for a major part of patients' morbidity and mortality after orthotopic liver transplantation (OLT). The exact origin of this type of biliary complication remains unknown. This study retrospectively evaluated 1843 patients. Patients with primary sclerosing cholangitis were excluded from this study. The diagnosis of ITBL was established only when all other causes of destruction of the biliary tree were ruled out. Donor age (P = 0.028) and cold ischemic time (CIT) (P = 0.002) were found to be significant risk factors for the development of ITBL. Organs that were perfused with University of Wisconsin (UW) solution developed ITBL significantly more often than Histidine-Tryptophan-Ketoglutarate (HTK)-perfused organs (P = 0.036). The same applied to organs harvested externally and shipped to our center versus those that were procured locally by our harvest teams (P < 0.001). Pressure perfusion via the hepatic artery significantly reduced the risk of ITBL (P = 0.001). The only recipient factor that showed a significant influence was Child-Pugh score status C (P = 0.021). Immunologic factors had no significant impact on ITBL. The clinical consequences of this study for our institution have been the strict limitation of CIT to <10 h and the exclusive use of HTK solution. We further advocate that all organ procurement teams perform pressure perfusion on harvested organs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19691661     DOI: 10.1111/j.1432-2277.2009.00947.x

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  40 in total

Review 1.  Strategies to optimize the use of marginal donors in liver transplantation.

Authors:  Daniele Pezzati; Davide Ghinolfi; Paolo De Simone; Emanuele Balzano; Franco Filipponi
Journal:  World J Hepatol       Date:  2015-11-18

Review 2.  How important is donor age in liver transplantation?

Authors:  Alberto Lué; Estela Solanas; Pedro Baptista; Sara Lorente; Juan J Araiz; Agustin Garcia-Gil; M Trinidad Serrano
Journal:  World J Gastroenterol       Date:  2016-06-07       Impact factor: 5.742

3.  The reduction rate of serum C3 following liver transplantation is an effective predictor of non-anastomotic strictures.

Authors:  Shuang Liu; Tonghai Xing; Tao Sheng; Shouwen Yang; Li Huang; Zhihai Peng; Xing Sun
Journal:  Hepatol Int       Date:  2014-03-06       Impact factor: 6.047

Review 4.  Acute liver failure: a life-threatening disease.

Authors:  Ali Canbay; Frank Tacke; Johannes Hadem; Christian Trautwein; Guido Gerken; Michael P Manns
Journal:  Dtsch Arztebl Int       Date:  2011-10-21       Impact factor: 5.594

5.  Biliary complications in liver transplantation: Impact of anastomotic technique and ischemic time on short- and long-term outcome.

Authors:  Stefan Kienlein; Wenzel Schoening; Anne Andert; Daniela Kroy; Ulf Peter Neumann; Maximilian Schmeding
Journal:  World J Transplant       Date:  2015-12-24

6.  Biliary complications following orthotopic liver transplantation: a 10-year audit.

Authors:  Nalaka Gunawansa; John L McCall; Andrew Holden; Lindsay Plank; Stephen R Munn
Journal:  HPB (Oxford)       Date:  2011-06       Impact factor: 3.647

7.  Can we reduce ischemic cholangiopathy rates in donation after cardiac death liver transplantation after 10 years of practice? Canadian single-centre experience

Authors:  Kerollos Wanis
Journal:  Can J Surg       Date:  2019-02-01       Impact factor: 2.089

8.  Clinical outcomes and costs associated with in-hospital biliary complications after liver transplantation: a cross-sectional analysis.

Authors:  Arun P Palanisamy; D J Taber; A G Sutter; S N Nadig; J E Dowden; J W McGillicuddy; P K Baliga; K D Chavin
Journal:  J Gastrointest Surg       Date:  2014-10-16       Impact factor: 3.452

9.  Donation after cardio-circulatory death liver transplantation.

Authors:  Hieu Le Dinh; Arnaud de Roover; Abdour Kaba; Séverine Lauwick; Jean Joris; Jean Delwaide; Pierre Honoré; Michel Meurisse; Olivier Detry
Journal:  World J Gastroenterol       Date:  2012-09-07       Impact factor: 5.742

10.  Hepatic artery bridging lessens temporary ischemic injury to bile canaliculi.

Authors:  Jia-Zhong Wang; Yang Liu; Jin-Long Wang; Le Lu; Ya-Fei Zhang; Hong-Wei Lu; Yi-Ming Li
Journal:  World J Gastroenterol       Date:  2015-09-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.